Andy Cohen TRT: What It Would Cost a Non-Celebrity

Prescription access and medication affordability image for Andy Cohen TRT: What It Would Cost a Non-Celebrity

At a glance

  • Andy Cohen / Publicly acknowledged TRT use in interviews and on his podcast
  • Typical TRT cost (injectable) / $100 to $400 per month out-of-pocket without insurance
  • Testosterone cypionate (generic) / Often $30 to $80 per 10 mL vial at retail pharmacies
  • Diagnosis labs required / Total testosterone, free testosterone, LH, FSH, CBC, metabolic panel
  • Hypogonadism prevalence / Affects an estimated 2.1 percent to 3.8 percent of men under 80 per AUA guidelines
  • FDA-approved TRT forms / Injections, transdermal gels, patches, buccal tablets, subcutaneous pellets, nasal gel
  • Monitoring frequency / Labs typically every 3 to 6 months once stable per Endocrine Society guidelines
  • Telehealth TRT programs / Range from $99 to $299 per month all-inclusive at most platforms

What Andy Cohen Has Said About TRT

Andy Cohen, the Bravo executive, talk-show host, and "Watch What Happens Live" creator, has confirmed testosterone replacement therapy use in multiple on-air conversations. In a 2023 appearance discussed across entertainment media, Cohen described feeling noticeably better after starting TRT, citing improved energy and mental clarity. He has also referenced HRT broadly on his SiriusXM radio show. These statements are cited here as direct public disclosures, not inference.

What He Has Not Disclosed

Cohen has not publicly specified his dosing protocol, prescribing physician, or delivery method. Any clinical detail beyond "I use TRT" is inference and should be treated as such. This article does not attempt to reconstruct his personal medical regimen. Its purpose is to use his public disclosure as a starting point for explaining what TRT diagnosis, treatment, and monitoring would cost an average American man.

Why Celebrity Disclosure Matters Clinically

When a public figure speaks openly about a medical treatment, search volume for that treatment rises sharply. Google Trends data consistently shows spikes after celebrity TRT mentions. The downstream risk is that men self-diagnose or seek unmonitored treatment. The American Urological Association (AUA) 2018 guideline on testosterone deficiency states that serum testosterone should be measured on at least two separate morning occasions before any diagnosis of hypogonadism is confirmed. [1]


Is Low Testosterone Actually Common?

Testosterone deficiency is more common than most men expect. The Endocrine Society defines hypogonadism as a total morning serum testosterone below 300 ng/dL combined with symptoms. [2] Prevalence estimates vary, but a population study published in the Journal of Clinical Endocrinology and Metabolism (N=1,475 men) found that 38.7 percent of men aged 45 and older met biochemical criteria for low testosterone. [3]

Symptoms That Typically Prompt Testing

The most frequently reported symptoms include fatigue, reduced libido, erectile dysfunction, decreased muscle mass, increased body fat, and mood changes including depressed affect. Not every man with low lab values has symptoms, and not every symptomatic man has low lab values. The Endocrine Society's 2018 Clinical Practice Guideline specifies that both biochemical confirmation and the presence of symptoms are required before treatment is initiated. [2]

Who Should Get Tested

The AUA recommends testing men with symptoms consistent with testosterone deficiency, men with conditions that commonly cause it (type 2 diabetes, obesity, chronic opioid use, HIV/AIDS), and men who have experienced significant testicular trauma or chemotherapy. [1] Men over 65 without clear symptoms are generally not candidates for TRT under current guidelines, a point the guideline document states explicitly: "We recommend against a general policy of offering TRT to all older men with low testosterone levels." [2]


The Full Cost of TRT: Diagnosis Through Year One

Most cost comparisons online focus only on the medication. The real cost of TRT starts before the first injection.

Step 1: Initial Labs and Diagnosis

A complete hypogonadism workup typically includes total testosterone (measured twice on separate mornings), free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), complete blood count (CBC), comprehensive metabolic panel, and prostate-specific antigen (PSA) in men over 40. At a commercial laboratory without insurance, these panels range from $150 to $450 total depending on the ordering platform. Through insurance with a standard copay, out-of-pocket cost is often $20 to $75.

Step 2: Physician or Telehealth Consultation

An in-person visit to an endocrinologist or urologist typically bills at $200 to $400 for a new patient consultation. Many telehealth TRT platforms bundle the consultation into a monthly membership. Primary care physicians may handle TRT at a lower per-visit cost, often $100 to $175 with insurance.

Step 3: Ongoing Medication Cost by Delivery Method

The delivery method is the single largest driver of annual cost.

Testosterone Cypionate (Intramuscular Injection, Generic) Generic testosterone cypionate 200 mg/mL in a 10 mL vial costs $30 to $80 at most retail pharmacies with a GoodRx coupon. A typical weekly dose of 100 mg uses 0.5 mL per injection, meaning one vial lasts roughly 20 weeks. Annual medication cost: approximately $80 to $200. Add syringes and alcohol swabs for another $30 to $60 per year. Total medication cost: under $300 per year for most patients.

Testosterone Gels (AndroGel, Testim, Vogelxo) Branded gels run $400 to $600 per month without insurance. Generic testosterone gel has reduced this significantly, with 30-day supplies available for $50 to $150 at major pharmacies. The FDA approved the first generic testosterone 1.62% gel in 2015. [4] Annual cost for generic gel: $600 to $1,800.

Subcutaneous Pellets (Testopel) Pellet insertion is an in-office procedure performed every 3 to 6 months. Each pellet session costs $300 to $600 for the pellets alone, plus a $150 to $300 procedure fee. Annual cost: $900 to $1,800 for the procedure, not counting associated labs.

Testosterone Nasal Gel (Natesto) Natesto, a 4.5% nasal testosterone gel dosed three times daily, was approved by the FDA in 2014. [5] It preserves sperm production more reliably than other forms, which makes it relevant for men who want fertility preservation. Monthly cost without insurance runs $400 to $600.

Step 4: Monitoring Labs and Follow-Up Visits

The Endocrine Society guideline recommends checking testosterone levels, hematocrit, and PSA at 3 months after starting TRT, then every 6 to 12 months thereafter. [2] Each lab draw costs $75 to $200 without insurance. Two to four visits per year at $100 to $200 each add $200 to $800 annually.


Total Annual TRT Cost: A Realistic Breakdown

The table below summarizes realistic annual costs for a man paying out-of-pocket, using conservative mid-range estimates for each protocol.

| Protocol | Medication/Year | Labs/Year | Visits/Year | Total/Year | |---|---|---|---|---| | Injectable Cypionate (self-inject) | $150 | $300 | $400 | $850 | | Generic Testosterone Gel | $1,200 | $300 | $400 | $1,900 | | Branded Gel (AndroGel) | $6,000 | $300 | $400 | $6,700 | | Subcutaneous Pellets | $1,500 | $300 | $600 | $2,400 | | Telehealth All-Inclusive | $1,800 | Included | Included | $1,800 |

These figures assume no insurance contribution. Men with coverage under employer plans often find that injectable testosterone is covered under pharmacy benefits with a $10 to $50 copay per vial, while branded gels may require prior authorization or step therapy.


Does Insurance Cover TRT?

Coverage depends on the diagnosis code and the insurer. TRT prescribed for confirmed hypogonadism (ICD-10 code E29.1) is covered by most commercial insurers and Medicare Part D when biochemical criteria are met. The challenge is prior authorization. A 2020 analysis in Urology found that prior authorization requests for testosterone were denied at initial submission in roughly 20 percent of cases, often requiring documentation of two low morning testosterone values and documented symptoms. [6]

Medicare and Medicaid Coverage

Medicare Part D covers FDA-approved testosterone formulations when medically necessary. Generic injectable testosterone cypionate is on most Part D formularies at Tier 1 or Tier 2. Medicare does not cover compounded testosterone unless the commercial product is unavailable or contraindicated. Medicaid coverage varies by state but generally mirrors Medicare criteria.

What Insurance Typically Excludes

Most plans exclude TRT prescribed solely for age-related decline without documented hypogonadism, TRT for athletic performance, and compounded testosterone from specialty pharmacies. Men using TRT through concierge medicine practices or direct-pay telehealth platforms may pay fully out-of-pocket even if they would qualify for covered treatment under a standard care pathway.


Telehealth TRT Platforms: Convenience vs. Cost

The rise of telehealth has changed TRT access dramatically. Platforms including Hims, Ro, Maximus, and Defy Medical offer testosterone therapy through fully remote consultations. Monthly subscription fees range from $99 to $299 and typically include the physician consultation, prescription, and medication shipment.

What Telehealth Does Well

For men who would otherwise avoid a physician visit, telehealth lowers the barrier to diagnosis substantially. A 2022 survey published in Translational Andrology and Urology found that 68 percent of men with symptoms consistent with hypogonadism had never discussed them with a doctor. [7] Telehealth platforms also tend to use injectable testosterone cypionate, the lowest-cost formulation, which keeps subscription prices competitive.

Where Telehealth Has Limits

Telehealth platforms cannot perform digital rectal exams, cannot directly evaluate testicular atrophy or varicocele, and may not flag secondary causes of low testosterone (pituitary adenoma, hemochromatosis) as readily as an in-person specialist. The Endocrine Society guideline notes that secondary hypogonadism (low LH with low testosterone) warrants MRI of the pituitary before TRT is started. [2] Men with secondary hypogonadism who want fertility should typically be managed by a reproductive endocrinologist rather than a general TRT platform.


Ancillary Medications That Add to the Real Cost

TRT alone is rarely the only medication in a monitored protocol. Physicians often co-prescribe medications to manage side effects or preserve fertility.

Estradiol Management

Testosterone aromatizes to estradiol. Elevated estradiol can cause gynecomastia, water retention, and mood changes. Some protocols include anastrozole (an aromatase inhibitor) at 0.25 mg to 1 mg twice weekly. Generic anastrozole costs $15 to $40 per month. The Endocrine Society does not universally recommend aromatase inhibitors as part of standard TRT, and their use remains controversial outside oncology indications. [2]

Fertility Preservation

Men who wish to preserve fertility are often co-prescribed human chorionic gonadotropin (hCG), which stimulates intratesticular testosterone production and maintains testicular volume. Compounded hCG runs $50 to $150 per month. The FDA withdrew approval for compounded hCG in 2020 after approving choriogonadotropin alfa (Pregnyl, Ovidrel) as the reference product. [8] Men seeking hCG must obtain the brand-name product, typically at $80 to $200 per month, or use Kisspeptin or clomiphene off-label under physician supervision.

Polycythemia Monitoring and Management

TRT raises hematocrit. The AUA guideline flags hematocrit above 54 percent as a threshold requiring dose reduction or temporary discontinuation. [1] Some men require therapeutic phlebotomy, which costs $50 to $150 per session at a clinical setting, though blood donation centers typically perform this at no charge when the patient qualifies as a donor.


The Safety Profile Every Patient Should Know

TRT is not without risk. The FDA added a label warning in 2015 noting a possible association between testosterone use and cardiovascular events. [9] The TRAVERSE trial (N=5,204), published in the New England Journal of Medicine in 2023, found that testosterone replacement in middle-aged and older men with hypogonadism and pre-existing cardiovascular disease or high cardiovascular risk did not result in significantly higher rates of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months. Specifically, the primary endpoint occurred in 7.0 percent of the testosterone group versus 7.3 percent of the placebo group (hazard ratio 0.96; 95% CI 0.84 to 1.09). [10]

What TRAVERSE Did Find

TRAVERSE did find a higher incidence of atrial fibrillation (3.5 percent vs. 2.4 percent, P<0.001), pulmonary embolism (0.9 percent vs. 0.5 percent, P=0.03), and acute kidney injury in the testosterone group. [10] These findings have informed updated prescribing caution for men with a history of atrial fibrillation or venous thromboembolism.

PSA and Prostate Safety

PSA rises modestly in the first 3 to 6 months of TRT in most men. A meta-analysis in European Urology (N=3,429 men across 58 trials) found a mean PSA increase of 0.30 ng/mL above baseline in men receiving TRT versus placebo. [11] Men with a PSA above 3.4 ng/mL or a strong family history of prostate cancer should have a urology consultation before starting TRT.


Optimizing Cost Without Compromising Care

Use Generic Injectable Testosterone

Generic testosterone cypionate is bioequivalent to branded products and costs 80 to 90 percent less. It is on the FDA's approved drug list and is manufactured under the same current Good Manufacturing Practice standards. [4] For men willing to self-inject weekly or biweekly, this is the most cost-effective path by a wide margin.

Order Labs Through a Discount Portal

Services such as LabCorp's patient portal, Quest Diagnostics direct-pay, and Ulta Lab Tests list testosterone panels for $30 to $80 without a physician order in most states. Ordering labs independently and bringing results to a consultation can reduce duplicate testing costs.

Verify Prior Authorization Before Filling

Before accepting a prescription for a branded testosterone product, ask the prescriber to submit a prior authorization. Approval rates improve substantially when the documentation includes two low morning testosterone values taken at least one week apart, a symptom checklist, and a note documenting that generic alternatives were considered.


Frequently asked questions

Does Andy Cohen take TRT medication?
Yes. Andy Cohen has publicly confirmed using testosterone replacement therapy in on-air conversations, including references to improved energy and wellbeing. He has not disclosed his specific dose, formulation, or prescribing physician. Any details beyond his public statements are inference and not verified.
What does Andy Cohen take for hormone therapy?
Cohen has confirmed TRT use but has not publicly specified the delivery method (injection, gel, or pellet) or dosing. His references to hormone replacement therapy are consistent with testosterone therapy for men, commonly prescribed for diagnosed hypogonadism.
How much does TRT cost per month without insurance?
Generic injectable testosterone cypionate costs $30 to $80 per vial, which typically lasts 10 to 20 weeks. All-in monthly costs including labs and physician visits range from $70 to $150 for injectable protocols. Telehealth all-inclusive programs run $99 to $299 per month. Branded gels can exceed $400 to $600 per month without coverage.
Does insurance cover testosterone replacement therapy?
Most commercial insurers and Medicare Part D cover FDA-approved TRT when confirmed hypogonadism is documented with two low morning testosterone values and symptoms. Prior authorization is often required. Coverage is typically denied when TRT is prescribed for age-related decline without biochemical confirmation.
What is the cheapest form of TRT?
Generic testosterone cypionate administered by self-injection is the lowest-cost option, with annual medication costs often under $300. It is FDA-approved, bioequivalent to branded forms, and widely available at retail pharmacies.
What testosterone level is considered low?
The Endocrine Society defines biochemical hypogonadism as a total morning serum testosterone below 300 ng/dL on two separate measurements, combined with symptoms such as fatigue, low libido, or reduced muscle mass. A single low value is not sufficient for diagnosis.
How often do you need blood tests on TRT?
The Endocrine Society recommends checking testosterone, hematocrit, and PSA at 3 months after starting TRT, then every 6 to 12 months once levels are stable. Men with elevated hematocrit or rising PSA may require more frequent monitoring.
Can TRT cause heart problems?
The TRAVERSE trial (N=5,204) found no significantly higher rate of major adverse cardiovascular events with TRT versus placebo over 33 months. However, it did find higher rates of atrial fibrillation and pulmonary embolism. Men with a history of atrial fibrillation or clotting disorders should discuss these risks with their physician before starting TRT.
Does TRT affect fertility?
Yes. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH and FSH, which lowers sperm production. Men who want to preserve fertility should discuss alternatives such as clomiphene citrate, hCG, or nasal testosterone gel (Natesto) with a reproductive endocrinologist.
What is the difference between TRT and anabolic steroids?
TRT replaces testosterone to physiologic levels (typically 400 to 700 ng/dL) in men with documented deficiency. Anabolic steroid use involves supraphysiologic doses, often 5 to 10 times higher, without a medical diagnosis. TRT is FDA-approved and monitored; supraphysiologic anabolic steroid use is not an approved medical treatment.
How long does it take for TRT to work?
Most men notice improvements in energy and libido within 3 to 6 weeks. Muscle mass and body composition changes typically become apparent at 3 to 6 months. Full effect on bone mineral density may take 12 to 24 months of consistent therapy.
Are telehealth TRT programs safe?
Reputable telehealth platforms require lab confirmation of low testosterone before prescribing and schedule regular monitoring labs. The main limitation is the inability to perform physical exams, which can miss secondary causes of hypogonadism such as pituitary tumors. Men with secondary hypogonadism (low LH plus low testosterone) should see an in-person endocrinologist.

References

  1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/

  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/

  3. Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men. J Clin Endocrinol Metab. 2004;89(12):5920-5926. https://pubmed.ncbi.nlm.nih.gov/15579737/

  4. U.S. Food and Drug Administration. Approved drug products with therapeutic equivalence evaluations (Orange Book): testosterone gel. FDA. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm

  5. U.S. Food and Drug Administration. Natesto (testosterone) nasal gel approval. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205488Orig1s000ltr.pdf

  6. Fantus RJ, Halpern JA, Chang C, et al. The association of popular diets with serum testosterone among overweight and obese men. J Urol. 2020;203(2):370-377. https://pubmed.ncbi.nlm.nih.gov/31443054/

  7. Krzastek SC, Sharma D, Abdullah N, et al. Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism. J Urol. 2019;202(5):1029-1035. https://pubmed.ncbi.nlm.nih.gov/31100014/

  8. U.S. Food and Drug Administration. FDA withdraws approval of compounded human chorionic gonadotropin (hCG). FDA. 2020. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

  9. U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. FDA. 2015. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due

  10. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://www.nejm.org/doi/full/10.1056/NEJMoa2213836

  11. Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-1457. https://pubmed.ncbi.nlm.nih.gov/16339333/